Edgewise Therapeutics (EWTX)
(Delayed Data from NSDQ)
$18.08 USD
+1.22 (7.21%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $19.53 +1.46 (8.05%) 6:36 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Brokerage Reports
Edgewise Therapeutics, Inc. [EWTX]
Reports for Purchase
Showing records 21 - 40 ( 82 total )
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
ARCH Data Continues to Show Stabilization - More Readouts To Come
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Notes From The (Virtual) Road... Cardiac In Focus As ARCH Data Arrives
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Let''s Get It Started -- Multiple Readouts Approaching
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Muscling Up The Balance Sheet Ahead Of Catalyst Rich 2024; Adding In EDG-7500
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Kickstart or False Start? What January Tells Us about Biotech Annual Returns
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Moving To A New Beat: Looking Closer At EDG-7500 In HCM
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Could 2024 Finally Be Biotech''s Breakthrough Year?
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for EWTX 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Will EWTX OutFOX The Competition With EDG-5506? Can''t Wait To Find Out
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Notes From The (Virtual) Road... DMD, Cardiac GLP-1s In Focus With EWTX
Provider: Wedbush Securities Inc.
Analyst: CHICO L